About Orange Grove Bio LLC
Orange Grove Bio LLC is a company based in New York (United States) founded in 2019 by Lutz B Giebel.. Orange Grove Bio LLC has raised $16.59 million across 1 funding round. Orange Grove Bio LLC offers products and services including Drug Development Platform, Platelet Preservation Additive, and Gene Therapy Platform. Orange Grove Bio LLC operates in a competitive market with competitors including Orakl Oncology, Oncodesign, LumaBridge, Lytica Therapeutics and Axios Biosciences, among others.
- Headquarter New York, United States
- Founders Lutz B Giebel
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Orange Grove Bio Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$16.59 M (USD)
in 1 rounds
-
Latest Funding Round
$16.59 M (USD), Series B
Aug 25, 2022
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Orange Grove Bio LLC
Orange Grove Bio LLC offers a comprehensive portfolio of products and services, including Drug Development Platform, Platelet Preservation Additive, and Gene Therapy Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for accelerating drug development through university partnerships
Additive enabling long-term platelet storage to address blood supply challenges
Non-viral platform for treating genetic diseases like cystic fibrosis
Unlock access to complete
Unlock access to complete
Funding Insights of Orange Grove Bio LLC
Orange Grove Bio LLC has successfully raised a total of $16.59M through 1 strategic funding round. The most recent funding activity was a Series B round of $16.59 million completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $16.6M
-
First Round
First Round
(25 Aug 2022)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2022 | Amount | Series B - Orange Grove Bio LLC | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Orange Grove Bio LLC
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Orange Grove Bio LLC
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Orange Grove Bio Llc Comparisons
Competitors of Orange Grove Bio LLC
Orange Grove Bio LLC operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orakl Oncology, Oncodesign, LumaBridge, Lytica Therapeutics and Axios Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Orakl Oncology is a precision oncology start-up that enables the emergence of rare oncology by connecting patient tumors to the world's 3rd best cancer center.
|
|
| domain | founded_year | HQ Location |
Preclinical assessment services for anti-cancer therapies are provided.
|
|
| domain | founded_year | HQ Location |
Provider of oncology clinical research, regulatory affairs, and data management services
|
|
| domain | founded_year | HQ Location |
Therapeutic drugs are developed for medical applications.
|
|
| domain | founded_year | HQ Location |
Creates innovative platforms for anti-cancer drug development.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Orange Grove Bio Llc
Frequently Asked Questions about Orange Grove Bio LLC
When was Orange Grove Bio LLC founded?
Orange Grove Bio LLC was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Where is Orange Grove Bio LLC located?
Orange Grove Bio LLC is headquartered in New York, United States. It is registered at New York, New York, United States.
Who is the current CEO of Orange Grove Bio LLC?
Ryan Fox is the current CEO of Orange Grove Bio LLC.
Is Orange Grove Bio LLC a funded company?
Orange Grove Bio LLC is a funded company, having raised a total of $16.59M across 1 funding round to date. The company's 1st funding round was a Series B of $16.59M, raised on Aug 25, 2022.
What does Orange Grove Bio LLC do?
Orange Grove Bio LLC provider of preclinical development services through providing healthcare solutions, biopharma outsourcing, cro, preclinical studies, and oncology. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Who are the top competitors of Orange Grove Bio LLC?
Orange Grove Bio LLC's top competitors include Oncodesign, Orakl Oncology and Lytica Therapeutics.
What products or services does Orange Grove Bio LLC offer?
Orange Grove Bio LLC offers Drug Development Platform, Platelet Preservation Additive, and Gene Therapy Platform.